Effects of the dual orexin receptor antagonist DORA‐22 on sleep in 5XFAD mice
Abstract Introduction Sleep disruption is a characteristic of Alzheimer's disease (AD) that may exacerbate disease progression. This study tested whether a dual orexin receptor antagonist (DORA) would enhance sleep and attenuate neuropathology, neuroinflammation, and cognitive deficits in an AD...
Saved in:
| Main Authors: | Marilyn J. Duncan, Hannah Farlow, Chairtra Tirumalaraju, Do‐Hyun Yun, Chanung Wang, James A. Howard, Madison N. Sanden, Bruce F. O'Hara, Kristen J. McQuerry, Adam D. Bachstetter |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.01.003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Orexin system and pathogenesis of sleep-wake cycle disturbances in narcolepsy
by: Yu. V. Gavrilov, et al.
Published: (2018-01-01) -
Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
by: Rebeka Bustamante Rocha, et al.
Published: (2023-05-01) -
Molecular Insights into the Interaction of Orexin 1 Receptor Antagonists: A Comprehensive Study Using Classical and Quantum Computational Methods
by: Caio Sena, et al.
Published: (2025-06-01) -
Tumor cell apoptosis mediated by the orexins
by: A. S. Diatlova, et al.
Published: (2021-06-01) -
Effects of Traumatic Brain Injury on the Orexin/Hypocretin System
by: Rebecca T. Somach, et al.
Published: (2025-01-01)